anonymous
Guest
anonymous
Guest
Hey “idiot”….other divisions HAVE adjusted goals down. I know of 3 times where this has happened.Goal is never adjusted down you idiot. Only up. And considering how poorly Spevigo has performed this year (just like previous years) it’s likely that this drug has little time left.BI should sell the asset off to a smaller biotech and let them try to resuscitate it. Take some money now to recoup the loss. Move existing sales force over to the mental health (if that even launches) digital therapeutic and hope for the best.